About: Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic
Creator	Bourlière, Marc Boursier, Jérôme Bureau, Christophe Dumortier, Jérôme Fontaine, Hélène Ganne-Carrié, Nathalie Leroy, Vincent Afef, French
source	Elsevier; Medline; PMC
abstract	This document, written by the French Association for the Study of the Liver (AFEF) board, aims to provide information to physicians involved in the care of patients with liver disease during the Coronavirus disease (COVID-19) epidemic. These are not based on a systematic review of the literature and a rigorous evaluation using the GRADE method. These are recommendations based on feedback from China available in the form of original articles or letters – for which the scientific evidence is often modest – and the rules put forward by American (1) and European (Boettler et al, 2020) hepatology societies, the French National Digestive Cancer Thesaurus (Di Fiore et al., 2020) and the Francophone Transplantation Society (4). These suggestions require adjustment according to the geographical particularities of the epidemic, available standard procedures and access to local resources. This document will be updated as regularly as possible according to the evolution of our knowledge and characteristics on the epidemic.
has issue date	2020-04-22(xsd:dateTime)
bibo:doi	10.1016/j.clinre.2020.04.001
bibo:pmid	32360055
has license	no-cc
sha1sum (hex)	312c8903180c20de646646dba9c50cf70427b2ce
schema:url	https://doi.org/10.1016/j.clinre.2020.04.001
resource representing a document's title	Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic
has PubMed Central identifier	PMC7174166
has PubMed identifier	32360055
schema:publication	Clin Res Hepatol Gastroenterol
resource representing a document's body	covid:312c8903180c20de646646dba9c50cf70427b2ce#body_text
is schema:about of	named entity 'medical prescription' named entity 'COVID' named entity 'surgical mask' named entity 'registered nurse' named entity 'COVID' named entity 'chest pain' named entity 'COVID' named entity 'SARS-CoV-2' named entity 'sclerotherapy' named entity 'tacrolimus' named entity 'COVID-19 infection' named entity 'prednisone' named entity 'AIH' named entity 'thoracic' named entity 'HCC' named entity 'mTOR inhibitor' named entity 'COVID-19' named entity 'blood sampling' named entity 'liver disease' named entity 'HDV' named entity 'infection' named entity 'hospital pharmacy' named entity 'surgical mask' named entity 'social isolation' named entity 'teleworking' named entity 'prednisolone' named entity 'Cellcept' named entity 'COVID' named entity 'liver' named entity 'ALAT' named entity 'liver' named entity 'immunosuppressants' named entity 'registered nurse' named entity 'autoimmune hepatitis' named entity 'phlebotomies' named entity 'COVID-19' named entity 'gastrointestinal haemorrhage' named entity 'mTOR inhibitor' named entity 'HDV' named entity 'mycophenolic acid' named entity 'Imurel' named entity 'nursing staff' named entity 'hygiene' named entity 'endoscopies' named entity 'SARS-CoV-2' named entity 'thoracic' named entity 'Cellcept' named entity 'receptor' named entity 'Cellcept' named entity 'HCV' named entity 'enzyme' named entity 'mycophenolic acid' named entity 'ng/mL' named entity 'risk-benefit' named entity 'receptor' named entity 'hepatotropic viruses' named entity 'teleworking' named entity 'surgical mask' named entity 'COVID-19' named entity 'calcineurin inhibitors' named entity 'follow-up' named entity 'mTOR inhibitor' named entity 'follow-up' named entity 'impaired renal function' named entity 'metabolic syndrome' named entity 'adrenal insufficiency' named entity 'clinically significant' named entity 'SARS-CoV-2' named entity 'Cellcept' named entity 'immunosuppressive' named entity 'immunosuppressive therapy' named entity 'autoimmune hepatitis' named entity 'drug users' named entity 'immunosuppressive therapy'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software